Literature DB >> 21454891

Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011.

G Raghu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21454891     DOI： 10.1183/09031936.00017711

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  37 in total

1.  Interstitial lung disease associated with anti-citrullinated peptide/protein antibody-positive anti-synthetase syndrome.

Authors:  Hideaki Yamakawa; Eri Hagiwara; Tae Iwasawa; Ryota Otoshi; Erina Tabata; Satoshi Ikeda; Ryo Okuda; Tomohisa Baba; Shinichiro Iso; Koji Okudela; Tamiko Takemura; Shinji Sato; Takashi Ogura
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 2.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 3.  Idiopathic pulmonary fibrosis in East Asian.

Authors:  Changbo Sun; Yanbin Sun; Hui Shen; Chunlu Yang; Shun Xu
Journal:  Intractable Rare Dis Res       Date:  2017-05

Review 4.  Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways.

Authors:  David A Schwartz
Journal:  Ann Am Thorac Soc       Date:  2018-11

5.  Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia.

Authors:  Matthew J Strand; David Sprunger; Gregory P Cosgrove; Evans R Fernandez-Perez; Stephen K Frankel; Tristan J Huie; Amy L Olson; Joshua Solomon; Kevin K Brown; Jeffrey J Swigris
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

6.  Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; David L Streiner; Kevin K Brown; Amanda Belkin; Kathy E Green; Frederick S Wamboldt
Journal:  Respir Med       Date:  2013-12-24       Impact factor: 3.415

7.  Targeting Inhibitor of Apoptosis Proteins Protects from Bleomycin-Induced Lung Fibrosis.

Authors:  Shanna L Ashley; Thomas H Sisson; Amanda K Wheaton; Kevin K Kim; Carol A Wilke; Iyabode O Ajayi; Natalya Subbotina; Shaomeng Wang; Colin S Duckett; Bethany B Moore; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

Review 8.  Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).

Authors:  Adelle S Jee; Tamera J Corte
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

9.  Use of a genealogical database demonstrates heritability of pulmonary fibrosis.

Authors:  Mary Beth Scholand; Hilary Coon; Roger Wolff; Lisa Cannon-Albright
Journal:  Lung       Date:  2013-07-19       Impact factor: 2.584

Review 10.  Idiopathic pulmonary fibrosis: early detection and referral.

Authors:  Justin M Oldham; Imre Noth
Journal:  Respir Med       Date:  2014-04-04       Impact factor: 3.415
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.